Retrospective Analysis of the Safety and Efficacy of AngioJet Rheolytic Thrombectomy for Acute Pulmonary Embolism: A Single-Center Study.

Abstract

BACKGROUND:

To investigate the efficacy, safety, and feasibility of AngioJet Rheolytic Thrombectomy (ART) in the treatment of acute pulmonary embolism (APE).

METHODS:

Twelve patients with intermediate- or high-risk APE received ART and were followed up for 6-32 months. The technical success rate, clinical success rate, mortality, complication, and ancillary and laboratory tests before and after operation were analyzed retrospectively.

RESULTS:

The technical and clinical success rates of ART were both 91.67% (11/12). Except for the patient who died of heart failure during the operation, the rest of patients had no serious complications. After operation, arterial oxygen partial pressure increased while hemoglobin and troponin decreased (P < 0.05). All patients were free of recurrence of APE after 6-32 months of follow-up. Pulmonary artery thrombosis significantly reduced or disappeared.

CONCLUSIONS:

ART is an effective treatment for intermediate- and high-risk APE. It quickly clears the main pulmonary artery thrombus, relieves pulmonary hypertension, and improves the long-term prognosis of patients.

• Authors: Shuming Shi, Chuanyong Li, Qiang Zhang, Guangfeng Zheng, Weijian Fan, Zhichang Pan, Jianjie Rong
• Journal: Annals of vascular surgery (Ann Vasc Surg) Vol. 92 Pg. 155-162 (May 2023) ISSN: 1615-5947 [Electronic] Netherlands
• PMID: 36682459 (Publication Type: Journal Article)
• Copyright: Copyright © 2023 Elsevier Inc. All rights reserved.

Topics

• Humans
• Animals
• Retrospective Studies
• Treatment Outcome
• Thrombectomy (adverse effects)
• Pulmonary Embolism (diagnostic imaging, surgery, complications)
• Acute Disease
• Hominidae